Light-Activated ointment shows promise for rare skin cancer
Disease control
Completed
This study tested a synthetic ointment (HyBryte) activated by visible light to treat mycosis fungoides, a type of skin lymphoma. Ten adults with early-stage disease received treatment for up to 54 weeks. The goal was to see if the ointment could reduce redness, scaling, and plaqu…
Phase: PHASE2 • Sponsor: Ellen Kim, MD • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC